Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  599 results for ""Antibodies, Viral""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants.

  • Authors : Guo L; Department of Emergency Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/immunology ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/chemistry SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2025 Apr 11; Vol. 21 (4), pp. e1013034. Date of Electronic Publication: 2025 Apr 11 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Interaction of the endogenous antibody response with activating FcγRs enhance control of Mayaro virus through monocytes.

  • Authors : Dunagan MM; Emerging Virus Immunity Unit, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.; Dábilla N

Subjects: Monocytes*/Monocytes*/Monocytes*/immunology ; Monocytes*/Monocytes*/Monocytes*/virology ; Receptors, IgG*/Receptors, IgG*/Receptors, IgG*/immunology

  • Source: PLoS pathogens [PLoS Pathog] 2025 Feb 24; Vol. 21 (2), pp. e1012944. Date of Electronic Publication: 2025 Feb 24 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting.

  • Authors : Seow J; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.; Jefferson GCE

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/virology SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2024 Nov 18; Vol. 20 (11), pp. e1012724. Date of Electronic Publication: 2024 Nov 18 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge.

  • Authors : Li B; State Key Laboratory of Virology, School of Public Health, Wuhan University, Wuhan, China.; Qin XR

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/immunology ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacology ; Phlebovirus*/Phlebovirus*/Phlebovirus*/immunology SFTS phlebovirus

  • Source: PLoS pathogens [PLoS Pathog] 2025 Jan 31; Vol. 21 (1), pp. e1012889. Date of Electronic Publication: 2025 Jan 31 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.

  • Authors : Edwards CT; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.; Karunakaran KA

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/therapy

  • Source: PLoS pathogens [PLoS Pathog] 2025 Jan 23; Vol. 21 (1), pp. e1012456. Date of Electronic Publication: 2025 Jan 23 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies.

  • Authors : McIlroy PR; Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, California, United States of America.; Pham LTM

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Machine Learning* ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2025 Jan 23; Vol. 21 (1), pp. e1012903. Date of Electronic Publication: 2025 Jan 23 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.

  • Authors : Bu F; Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.; Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America.

Subjects: Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/pharmacology ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/immunology ; Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/drug therapy

  • Source: PLoS pathogens [PLoS Pathog] 2024 Dec 23; Vol. 20 (12), pp. e1012817. Date of Electronic Publication: 2024 Dec 23 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization.

  • Authors : Qing E; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, United States of America.; Salgado J

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/physiology ; Virus Internalization* SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2024 Dec 02; Vol. 20 (12), pp. e1012757. Date of Electronic Publication: 2024 Dec 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1.

  • Authors : Dong H; Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing, China.; Zhou R

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2024 Nov 11; Vol. 20 (11), pp. e1012625. Date of Electronic Publication: 2024 Nov 11 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.

  • Authors : Ruiz F; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, United States of America.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Cross Reactions*/Cross Reactions*/Cross Reactions*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology SARS-CoV-2 variants

  • Source: PLoS pathogens [PLoS Pathog] 2024 Oct 28; Vol. 20 (10), pp. e1012650. Date of Electronic Publication: 2024 Oct 28 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  599 results for ""Antibodies, Viral""